Johnson & Johnson announced the separation of its Consumer Health business and the IPO of its new public company, Kenvue Inc., resulting in net proceeds of $4.2 billion. The company later completed the disposition of shares of Kenvue Common Stock and exchanged its remaining shares for commercial paper.